
Axcella Health Inc.
Axcella Health Inc.(AXLA)内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签;可在本季度与近12个月之间切换;下方为季度图与交易明细。
SEC EDGAR · FMP · AXLA · 截至 2026年6月9日
活动摘要
买入笔数
12
P-Purchase only
卖出笔数
6
近12个月
买卖比
2.00
Buy/Sell (by trades)
整体情绪
Axcella Health Inc.内部人在过去近12个月净买入股份,可能反映对公司前景的信心。
▸ 数据来源:SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
AXLA 季度内部人买卖趋势
AXLA 内幕交易卖出 · AXLA 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源:SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
近期内幕交易记录
AXLA 高管卖出股份 · AXLA 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Mar 1, 2023 | Koziel Margaret Chief Medical Officer | Sale | 679 | $394 | Form 4 |
| Feb 10, 2023 | Fehlner Paul SVP & Chief Legal Officer | Sale | 5,221 | $3K | Form 4 |
| Oct 17, 2022 | Hinshaw William President & CEO | Award | 50,000 | — | Form 4 |
| Oct 19, 2022 | Hinshaw William President & CEO | Sale | 16,000 | $25K | Form 4 |
| Oct 13, 2022 | AFEYAN NOUBAR Director | Purchase | 2,757,333 | $4.52M⚡ | Form 4 |
| Oct 13, 2022 | Flagship Ventures Fund IV General Partner LLC 10 percent owner | Purchase | 2,757,333 | $4.52M⚡ | Form 4 |
| Oct 13, 2022 | AFEYAN NOUBAR Director | Purchase | 2,743,902 | $4.50M⚡ | Form 4 |
| Oct 13, 2022 | Flagship Ventures Fund IV General Partner LLC 10 percent owner | Purchase | 2,743,902 | $4.50M⚡ | Form 4 |
| Oct 13, 2022 | Flagship Ventures Fund IV General Partner LLC 10 percent owner | Purchase | 919,111 | $1.51M⚡ | Form 4 |
| Oct 13, 2022 | AFEYAN NOUBAR Director | Purchase | 919,111 | $1.51M⚡ | Form 4 |
| Oct 13, 2022 | AFEYAN NOUBAR Director | Purchase | 914,634 | $1.50M⚡ | Form 4 |
| Oct 13, 2022 | Flagship Ventures Fund IV General Partner LLC 10 percent owner | Purchase | 914,634 | $1.50M⚡ | Form 4 |
| Oct 13, 2022 | Flagship Ventures Fund IV General Partner LLC 10 percent owner | Purchase | 3,048,780 | $5.00M⚡ | Form 4 |
| Oct 13, 2022 | AFEYAN NOUBAR Director | Purchase | 3,048,780 | $5.00M⚡ | Form 4 |
| Oct 13, 2022 | Societe des Produits Nestle S.A. 10 percent owner | Purchase | 3,658,536 | $6.00M⚡ | Form 4 |
| Oct 13, 2022 | NESTLE SA Director | Purchase | 3,658,536 | $6.00M⚡ | Form 4 |
| May 19, 2022 | Epstein David R Director | Award | 47,059 | — | Form 4 |
| Jun 1, 2022 | Koziel Margaret Chief Medical Officer | Sale | 590 | $1K | Form 4 |
| Mar 16, 2022 | Hinshaw William President & CEO | Purchase | 13,089 | $25K | Form 4 |
| Mar 16, 2022 | Fehlner Paul SVP & Chief Legal Officer | Purchase | 10,471 | $20K | Form 4 |
| Mar 16, 2022 | Epstein David R Director | Purchase | 26,178 | $50K | Form 4 |
| Mar 16, 2022 | Crane Robert CFO | Purchase | 39,267 | $75K | Form 4 |
| Mar 16, 2022 | Flagship Ventures Fund IV General Partner LLC 10 percent owner | Purchase | 3,791,623 | $7.24M⚡ | Form 4 |
| Mar 16, 2022 | AFEYAN NOUBAR Director | Purchase | 1,579,843 | $3.02M⚡ | Form 4 |
| Mar 16, 2022 | Flagship Ventures Fund IV General Partner LLC 10 percent owner | Purchase | 1,579,843 | $3.02M⚡ | Form 4 |
Flagship Ventures Fund IV General Partner LLC
10 percent owner
日期
Oct 13
股数
2,757,333
均价
$1.64
总金额
$4.52M ⚡
Flagship Ventures Fund IV General Partner LLC
10 percent owner
日期
Oct 13
股数
2,743,902
均价
$1.64
总金额
$4.50M ⚡
Flagship Ventures Fund IV General Partner LLC
10 percent owner
日期
Oct 13
股数
919,111
均价
$1.64
总金额
$1.51M ⚡
Flagship Ventures Fund IV General Partner LLC
10 percent owner
日期
Oct 13
股数
914,634
均价
$1.64
总金额
$1.50M ⚡
Flagship Ventures Fund IV General Partner LLC
10 percent owner
日期
Oct 13
股数
3,048,780
均价
$1.64
总金额
$5.00M ⚡
Societe des Produits Nestle S.A.
10 percent owner
日期
Oct 13
股数
3,658,536
均价
$1.64
总金额
$6.00M ⚡
Flagship Ventures Fund IV General Partner LLC
10 percent owner
日期
Mar 16
股数
3,791,623
均价
$1.91
总金额
$7.24M ⚡
Flagship Ventures Fund IV General Partner LLC
10 percent owner
日期
Mar 16
股数
1,579,843
均价
$1.91
总金额
$3.02M ⚡
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源:SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 AXLA 内幕交易
AXLA 内幕交易
Axcella Health Inc.(AXLA)内幕交易数据来源于公司内部人(包括AXLA)提交的SEC Form 4申报文件。过去12个月内,0位内部人向SEC提交了交易申报。AXLA内部人近期主要在买入,这可能反映预设的10b5-1计划执行,而非方向性判断。
如需查看Axcella Health Inc.机构持仓比例和内部人持股百分比,请访问持仓(Ownership)标签页 → Ownership tab →
常见问题
AXLA 内幕交易 · 5个问题Axcella Health Inc.(AXLA)的内部人包括高管和董事,如AXLA等。过去12个月内,0位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源:FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026